Generics Clinical Development
Deliver clinical endpoint trials quickly and cost-effectively
Generic drug development comes with distinct demands, including timing and pricing pressures, and complex global execution. Quintiles’ lean delivery model adapts our proven processes and world-class resources to help you rapidly and predictably execute your clinical endpoint studies – all at a competitive price.
Take advantage of our global site and delivery networks for fast, efficient results
Quintiles global study network includes 25 Prime Sites, over 1,200 partner sites and 36,000+ partner investigators